Intertek’s Cell and Gene Therapy team provide analytical method development, validation, characterisation and QC testing services to support Early Stage Development, Clinical Phases and Manufacturing. This includes cell and virus characterisation, viral vector identity, virology assays, GMP and CMC services such as method development/validation, stability programs and QC release testing. We also provide specialist expertise in GCP/GLP bioanalysis, inhalation/nasal drug development and GXP auditing.